Back
Precigen, Inc. 10K Form
Sell
32
PGEN
Precigen, Inc.
Last Price:
$3.61
Seasonality Move:
11.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PGEN News And Ratings
See the #1 stock for the next 7 days that we like better than PGEN
PGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $3.9M |
|---|---|
| Cash Flow: | $-29.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.12 |
| Price / Book: | 30.42 |
Profitability
| EPS (TTM): | -1.40080 |
|---|---|
| Net Income (TTM): | $-246.9M |
| Gross Margin: | $-3.4M |
| Return on Equity: | -711.28% |
| Return on Assets: | -195.32% |
Precigen, Inc. Earnings Forecast
Key Precigen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for PGEN is -86.65%.
-
The Selling, General & Administrative Expenses for PGEN have been equal to 1,052.05% of Gross Profit Margin.
-
The Research & Development expenses have been 1,274.17% of Revenue.
-
The Net Earning history of PGEN is -3,216.18% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Precigen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PGEN |
| CUSIP: | 74017N |
| Website: | precigen.com |
Debt
| Debt-to-Equity Ratio: | 2.35 |
|---|---|
| Current Ratio: | 4.04 |
| Quick Ratio: | 3.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 65 |
PGEN Technical Analysis vs Fundamental Analysis
Sell
32
Precigen, Inc. (PGEN)
is a Sell
Is Precigen, Inc. a Buy or a Sell?
-
Precigen, Inc. stock is rated a SellThe current Precigen, Inc. [PGEN] share price is $3.60. The Score for PGEN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.